{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:51:07Z","timestamp":1781826667194,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10151-026-03312-w","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:45:27Z","timestamp":1777639527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Short- and mid-term outcomes of transanal\/transperineal minimally invasive surgery for locally recurrent rectal cancer"],"prefix":"10.1007","volume":"30","author":[{"given":"Y.","family":"Tsukada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ikeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1101-2707","authenticated-orcid":false,"given":"M.","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"3312_CR1","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/bjs.10734","volume":"105","author":"PelvEx Collaborative","year":"2018","unstructured":"PelvEx Collaborative (2018) Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer. Br J Surg 105:650\u2013657. https:\/\/doi.org\/10.1002\/bjs.10734","journal-title":"Br J Surg"},{"key":"3312_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/sla.0000000000001524","volume":"264","author":"CA Harris","year":"2016","unstructured":"Harris CA, Solomon MJ, Heriot AG et\u00a0al. (2016) The outcomes and patterns of treatment failure after surgery for locally recurrent rectal cancer. Ann Surg 264:323\u2013329. https:\/\/doi.org\/10.1097\/sla.0000000000001524","journal-title":"Ann Surg"},{"key":"3312_CR3","doi-asserted-by":"publisher","first-page":"e766","DOI":"10.1097\/sla.0000000000005799","volume":"278","author":"EA Dijkstra","year":"2023","unstructured":"Dijkstra EA, Nilsson PJ, Hospers GAP et\u00a0al. (2023) Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared to long-course chemoradiotherapy and surgery: a five-year follow-up of the RAPIDO trial. Ann Surg 278:e766\u2013e772. https:\/\/doi.org\/10.1097\/sla.0000000000005799","journal-title":"Ann Surg"},{"key":"3312_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/as9.0000000000000579","volume":"6","author":"Y Tsukada","year":"2025","unstructured":"Tsukada Y, Saito N, Nishizawa Y et\u00a0al. (2025) Neoadjuvant chemotherapy versus adjuvant chemotherapy for very low-lying clinical T3 rectal cancer: the NAIR phase 2\/3 randomized clinical trial. Ann Surg Open 6:e579. https:\/\/doi.org\/10.1097\/as9.0000000000000579","journal-title":"Ann Surg Open"},{"key":"3312_CR5","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1007\/s00464-013-2872-0","volume":"27","author":"AM de Lacy","year":"2013","unstructured":"de Lacy AM, Rattner DW, Adelsdorfer C et\u00a0al. (2013) Transanal natural orifice transluminal endoscopic surgery (NOTES) rectal resection: \u201cdown-to-up\u201d total mesorectal excision (TME)\u2013short-term outcomes in the first 20 cases. Surg Endosc 27:3165\u20133172. https:\/\/doi.org\/10.1007\/s00464-013-2872-0","journal-title":"Surg Endosc"},{"key":"3312_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/sla.0000000000001948","volume":"266","author":"M Penna","year":"2017","unstructured":"Penna M, Hompes R, Arnold S et\u00a0al. (2017) Transanal total mesorectal excision: international registry results of the first 720 cases. Ann Surg 266:111\u2013117. https:\/\/doi.org\/10.1097\/sla.0000000000001948","journal-title":"Ann Surg"},{"key":"3312_CR7","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1007\/s00464-023-09948-1","volume":"37","author":"T Adachi","year":"2023","unstructured":"Adachi T, Kitaguchi D, Teramura K et\u00a0al. (2023) Single-center comparative study of short-term outcomes of transanal and laparoscopic total mesorectal excisions for low and middle rectal cancers. Surg Endosc 37:4698\u20134706. https:\/\/doi.org\/10.1007\/s00464-023-09948-1","journal-title":"Surg Endosc"},{"key":"3312_CR8","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s10151-023-02869-0","volume":"27","author":"N Beppu","year":"2023","unstructured":"Beppu N, Ito K, Otani M et\u00a0al. (2023) Feasibility of transanal minimally invasive surgery for total pelvic exenteration for advanced primary and recurrent pelvic malignancies. Tech Coloproctol 27:1367\u20131375. https:\/\/doi.org\/10.1007\/s10151-023-02869-0","journal-title":"Tech Coloproctol"},{"key":"3312_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s10151-024-02954","volume":"28","author":"N Beppu","year":"2024","unstructured":"Beppu N, Ito K, Otani M et\u00a0al. (2024) Feasibility of transperineal minimal invasive surgery when performing sacrectomy for advanced primary and recurrent pelvic malignancies. Tech Coloproctol 28:80. https:\/\/doi.org\/10.1007\/s10151-024-02954","journal-title":"Tech Coloproctol"},{"key":"3312_CR10","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/jjco\/hyaa127","volume":"55","author":"T Yokoyama","year":"2025","unstructured":"Yokoyama T, Uehara K, Yamada T et\u00a0al. (2025) Current surgical treatment strategies and ongoing issues for locally recurrent rectal cancer. Jpn J Clin Oncol 55:1217\u20131228. https:\/\/doi.org\/10.1093\/jjco\/hyaa127","journal-title":"Jpn J Clin Oncol"},{"key":"3312_CR11","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/jjco\/hyaa058","volume":"50","author":"T Kadota","year":"2020","unstructured":"Kadota T, Tsukada Y, Ito M et\u00a0al. (2020) A phase III randomized controlled trial comparing surgery plus adjuvant chemotherapy with preoperative chemoradiotherapy followed by surgery plus adjuvant chemotherapy for locally recurrent rectal cancer: Japan Clinical Oncology Group study JCOG1801 (RC-SURVIVE study). Jpn J Clin Oncol 50:953\u2013957. https:\/\/doi.org\/10.1093\/jjco\/hyaa058","journal-title":"Jpn J Clin Oncol"},{"key":"3312_CR12","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/dcr.0000000000003300","volume":"67","author":"Y Suzuki","year":"2024","unstructured":"Suzuki Y, Hasegawa H, Mori T et\u00a0al. (2024) Cytological analysis of the surgical field during transanal total mesorectal excision for rectal cancer: a prospective study. Dis Colon Rectum 67:1009\u20131017. https:\/\/doi.org\/10.1097\/dcr.0000000000003300","journal-title":"Dis Colon Rectum"},{"key":"3312_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00384-019-03490-0","volume":"35","author":"H Hasegawa","year":"2020","unstructured":"Hasegawa H, Tsukada Y, Wakabayashi M et\u00a0al. (2020) Impact of intraoperative indocyanine green fluorescence angiography on anastomotic leakage after laparoscopic sphincter-sparing surgery for malignant rectal tumors. Int J Colorectal Dis 35:471\u2013480. https:\/\/doi.org\/10.1007\/s00384-019-03490-0","journal-title":"Int J Colorectal Dis"},{"key":"3312_CR14","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s00595-022-02597-2","volume":"53","author":"T Yoshioka","year":"2023","unstructured":"Yoshioka T, Hasegawa H, Ikeda K et\u00a0al. (2023) Efficacy of transperineal minimally invasive surgery with laparoscopic abdominoperineal excision for lower rectal cancer. Surg Today 53:490\u2013498. https:\/\/doi.org\/10.1007\/s00595-022-02597-2","journal-title":"Surg Today"},{"key":"3312_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s10151-024-03083-2","volume":"29","author":"Y Tsukada","year":"2025","unstructured":"Tsukada Y, Ito M (2025) Reversed anatomy in transanal lateral lymph node dissection: landmarks and pitfalls. Tech Coloproctol 29:54. https:\/\/doi.org\/10.1007\/s10151-024-03083-2","journal-title":"Tech Coloproctol"},{"key":"3312_CR16","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/BF02054435","volume":"39","author":"K Suzuki","year":"1996","unstructured":"Suzuki K, Dozois RR, Devine RM et\u00a0al. (1996) Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 39:730\u2013736. https:\/\/doi.org\/10.1007\/BF02054435","journal-title":"Dis Colon Rectum"},{"key":"3312_CR17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ejso.2009.11.011","volume":"36","author":"M Kusters","year":"2010","unstructured":"Kusters M, Marijnen CA, van de Velde CJ et\u00a0al. (2010) Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 36:470\u2013476. https:\/\/doi.org\/10.1016\/j.ejso.2009.11.011","journal-title":"Eur J Surg Oncol"},{"key":"3312_CR18","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.ijrobp.2006.02.050","volume":"65","author":"S Roels","year":"2006","unstructured":"Roels S, Duthoy W, Haustermans K et\u00a0al. (2006) Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 65:1129\u20131142. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.02.050","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3312_CR19","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/codi.16535","volume":"25","author":"Y Tsukada","year":"2023","unstructured":"Tsukada Y, Rullier E, Shiraishi T et\u00a0al. (2023) Comparison between preoperative chemoradiotherapy and lateral pelvic lymph node dissection in clinical T3 low rectal cancer without enlarged lateral lymph nodes. Colorectal Dis 25:1153\u20131162. https:\/\/doi.org\/10.1111\/codi.16535","journal-title":"Colorectal Dis"},{"key":"3312_CR20","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s11605-014-2537-x","volume":"18","author":"T Nagasaki","year":"2014","unstructured":"Nagasaki T, Akiyoshi T, Ueno M et\u00a0al. (2014) Laparoscopic salvage surgery for locally recurrent rectal cancer. J Gastrointest Surg 18:1319\u20131326. https:\/\/doi.org\/10.1007\/s11605-014-2537-x","journal-title":"J Gastrointest Surg"},{"key":"3312_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s10151-024-02977-5","volume":"28","author":"J Zhang","year":"2024","unstructured":"Zhang J, Huang F, Niu R et\u00a0al. (2024) Short-term and long-term outcomes of laparoscopic surgery for locally recurrent rectal cancer: a propensity score-matched cohort study. Tech Coloproctol 28:100. https:\/\/doi.org\/10.1007\/s10151-024-02977-5","journal-title":"Tech Coloproctol"},{"key":"3312_CR22","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/bjs5.50153","volume":"3","author":"PelvEx Collaborative","year":"2019","unstructured":"PelvEx Collaborative (2019) Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer. BJS Open 3:516\u2013520. https:\/\/doi.org\/10.1002\/bjs5.50153","journal-title":"BJS Open"},{"key":"3312_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/codi.17239","volume":"27","author":"S Hirata","year":"2025","unstructured":"Hirata S, Kanemitsu Y, Moritani K et\u00a0al. (2025) A pedicled anterolateral thigh flap decreased the risk of empty pelvis syndrome following total pelvic exenteration. Colorectal Dis 27:e17239. https:\/\/doi.org\/10.1111\/codi.17239","journal-title":"Colorectal Dis"},{"key":"3312_CR24","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1097\/js9.0000000000000617","volume":"109","author":"NJ Galbraith","year":"2023","unstructured":"Galbraith NJ, McCollum C, Di Mascio L et\u00a0al. (2023) Effect of differing flap reconstruction strategies in perineal closure following advanced pelvic oncological resection: a retrospective cohort study. Int J Surg 109:3375\u20133382. https:\/\/doi.org\/10.1097\/js9.0000000000000617","journal-title":"Int J Surg"},{"key":"3312_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-073217","volume":"13","author":"T Hashimoto","year":"2023","unstructured":"Hashimoto T, Tsukada Y, Ito M et\u00a0al. (2023) Utility of circulating tumour DNA for prognosis and prediction of therapeutic effect in locally recurrent rectal cancer: study protocol for a multi-institutional, prospective observational study (JCOG1801A1, CAP-LR study). BMJ Open 13:e073217. https:\/\/doi.org\/10.1136\/bmjopen-2023-073217","journal-title":"BMJ Open"},{"key":"3312_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrab029","volume":"5","author":"PelvEx Collaborative","year":"2021","unstructured":"PelvEx Collaborative (2021) Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II). BJS Open 5:zrab029. https:\/\/doi.org\/10.1093\/bjsopen\/zrab029","journal-title":"BJS Open"},{"key":"3312_CR27","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1111\/codi.15670","volume":"23","author":"Q Denost","year":"2021","unstructured":"Denost Q, Frison E, Salut C et\u00a0al. (2021) A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as preoperative treatment for locally recurrent rectal cancer - GRECCAR 15 trial protocol. Colorectal Dis 23:1909\u20131918. https:\/\/doi.org\/10.1111\/codi.15670","journal-title":"Colorectal Dis"},{"key":"3312_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/bjs.11459","volume":"107","author":"HH Wasmuth","year":"2020","unstructured":"Wasmuth HH, Faerden AE, Myklebust T et\u00a0al. (2020) Transanal total mesorectal excision for rectal cancer has been suspended in Norway. Br J Surg 107:121\u2013130. https:\/\/doi.org\/10.1002\/bjs.11459","journal-title":"Br J Surg"},{"key":"3312_CR29","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/codi.16982","volume":"26","author":"E Neary","year":"2024","unstructured":"Neary E, Ibrahim T, Verschoor CP et\u00a0al. (2024) A systematic review and meta-analysis of oncological outcomes with transanal total mesorectal excision for rectal cancer. Colorectal Dis 26:837\u2013850. https:\/\/doi.org\/10.1111\/codi.16982","journal-title":"Colorectal Dis"},{"key":"3312_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrae044","volume":"8","author":"N de'Angelis","year":"2024","unstructured":"de\u2019Angelis N, Marchegiani F, Mart\u00ednez-P\u00e9rez A et\u00a0al. (2024) Robotic, transanal, and laparoscopic total mesorectal excision for locally advanced mid\/low rectal cancer: European multicentre, propensity score-matched study. BJS Open 8:zrae044. https:\/\/doi.org\/10.1093\/bjsopen\/zrae044","journal-title":"BJS Open"},{"key":"3312_CR31","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1001\/jama.2024.24276","volume":"333","author":"Z Zeng","year":"2025","unstructured":"Zeng Z, Luo S, Zhang H et\u00a0al. (2025) Transanal vs laparoscopic total mesorectal excision and 3-year disease-free survival in rectal cancer: the TaLaR randomized clinical trial. JAMA 333:774\u2013783. https:\/\/doi.org\/10.1001\/jama.2024.24276","journal-title":"JAMA"},{"key":"3312_CR32","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1007\/s00464-015-4615-x","volume":"30","author":"CL Deijen","year":"2016","unstructured":"Deijen CL, Velthuis S, Tsai A et\u00a0al. (2016) COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc 30:3210\u20133215. https:\/\/doi.org\/10.1007\/s00464-015-4615-x","journal-title":"Surg Endosc"}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10151-026-03312-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-026-03312-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-026-03312-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:56:29Z","timestamp":1781823389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10151-026-03312-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["3312"],"URL":"https:\/\/doi.org\/10.1007\/s10151-026-03312-w","relation":{},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"value":"1123-6337","type":"print"},{"value":"1128-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The study was approved by the Institutional Review Board of National Cancer Center Hospital East (2018\u2013100). The requirement for individual informed consent was waived due to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"It is written as \" Individual informed consent was waived due to the study\u2019s retrospective nature.\" in the Studydesign and Patients section.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"77"}}